Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...

Eli Lilly said copycat versions of Zepbound that add B12 result in potentially dangerous impurities. The compounding industry says there’s not enough information to issue warnings.

Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...

Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

When approved drugs do not exist for a species, condition or delivery route, compounded medications can fill the gap. These formulations provide new flexibility for managing livestock health.

Compounded NAD+ Telehealth Access, FDA Classification, Pharmacy Sourcing Standards, Prescription Requirements, and Consumer ...

Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could alter the drug’s toxicity profile and pose safety risks to patients, the ...

Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...